Bellevue Group’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-12,939
| Closed | -$521K | – | 167 |
|
|
2024
Q4 | $521K | Sell |
12,939
-3,240
| -20% | -$130K | 0.01% | 125 |
|
|
2024
Q3 | $1.02M | Buy |
16,179
+11,779
| +268% | +$746K | 0.02% | 118 |
|
|
2024
Q2 | $233K | Sell |
4,400
-1,000
| -19% | -$53K | ﹤0.01% | 144 |
|
|
2024
Q1 | $443K | Sell |
5,400
-12,100
| -69% | -$992K | 0.01% | 134 |
|
|
2023
Q4 | $326K | Buy |
+17,500
| New | +$326K | 0.01% | 146 |
|
|
2023
Q3 | – | Sell |
-33,000
| Closed | -$535K | – | 164 |
|
|
2023
Q2 | $535K | Buy |
+33,000
| New | +$535K | 0.01% | 142 |
|
|
2019
Q3 | – | Sell |
-96,000
| Closed | -$797K | – | 220 |
|
|
2019
Q2 | $797K | Buy |
+96,000
| New | +$797K | 0.01% | 143 |
|